vs
EVI INDUSTRIES, INC.（EVI）与ROGERS CORP（ROG）财务数据对比。点击上方公司名可切换其他公司
ROGERS CORP的季度营收约是EVI INDUSTRIES, INC.的1.7倍（$200.5M vs $115.3M），ROGERS CORP净利率更高（2.2% vs 2.1%，领先0.2%），EVI INDUSTRIES, INC.同比增速更快（24.4% vs 5.2%），过去两年EVI INDUSTRIES, INC.的营收复合增速更高（17.2% vs -3.3%）
EVI Industries是一家商用洗衣、干洗及衣物护理设备的领先分销商，主要服务北美市场，客户涵盖自助洗衣店、酒店、医疗机构及多户住宅物业，同时提供设备安装、维护及售后支持服务。
罗杰斯公司是一家专注于特种工程材料研发生产的企业，总部位于美国亚利桑那州钱德勒市，其产品广泛应用于先进电子、移动通信、清洁能源、航空航天等多个高科技领域，为全球客户提供高性能材料解决方案。
EVI vs ROG — 直观对比
营收规模更大
ROG
是对方的1.7倍
$115.3M
营收增速更快
EVI
高出19.1%
5.2%
净利率更高
ROG
高出0.2%
2.1%
两年增速更快
EVI
近两年复合增速
-3.3%
损益表 — Q2 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $115.3M | $200.5M |
| 净利润 | $2.4M | $4.5M |
| 毛利率 | 30.8% | 32.2% |
| 营业利润率 | 3.7% | — |
| 净利率 | 2.1% | 2.2% |
| 营收同比 | 24.4% | 5.2% |
| 净利润同比 | 109.9% | 421.4% |
| 每股收益（稀释后） | $0.15 | $0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EVIROG
| Q1 26 | — | $200.5M | ||
| Q4 25 | $115.3M | $201.5M | ||
| Q3 25 | $108.3M | $216.0M | ||
| Q2 25 | $110.0M | $202.8M | ||
| Q1 25 | $93.5M | $190.5M | ||
| Q4 24 | $92.7M | $192.2M | ||
| Q3 24 | $93.6M | $210.3M | ||
| Q2 24 | $90.1M | $214.2M |
净利润EVIROG
| Q1 26 | — | $4.5M | ||
| Q4 25 | $2.4M | $4.6M | ||
| Q3 25 | $1.8M | $8.6M | ||
| Q2 25 | $2.1M | $-73.6M | ||
| Q1 25 | $1.0M | $-1.4M | ||
| Q4 24 | $1.1M | $-500.0K | ||
| Q3 24 | $3.2M | $10.7M | ||
| Q2 24 | $2.1M | $8.1M |
毛利率EVIROG
| Q1 26 | — | 32.2% | ||
| Q4 25 | 30.8% | 31.5% | ||
| Q3 25 | 31.3% | 33.5% | ||
| Q2 25 | 30.8% | 31.6% | ||
| Q1 25 | 30.0% | 29.9% | ||
| Q4 24 | 29.7% | 32.1% | ||
| Q3 24 | 30.8% | 35.2% | ||
| Q2 24 | 30.4% | 34.1% |
营业利润率EVIROG
| Q1 26 | — | — | ||
| Q4 25 | 3.7% | 3.5% | ||
| Q3 25 | 3.3% | 7.3% | ||
| Q2 25 | 3.7% | -33.3% | ||
| Q1 25 | 2.4% | -0.2% | ||
| Q4 24 | 2.6% | -6.6% | ||
| Q3 24 | 5.3% | 6.9% | ||
| Q2 24 | 4.1% | 5.3% |
净利率EVIROG
| Q1 26 | — | 2.2% | ||
| Q4 25 | 2.1% | 2.3% | ||
| Q3 25 | 1.7% | 4.0% | ||
| Q2 25 | 1.9% | -36.3% | ||
| Q1 25 | 1.1% | -0.7% | ||
| Q4 24 | 1.2% | -0.3% | ||
| Q3 24 | 3.5% | 5.1% | ||
| Q2 24 | 2.3% | 3.8% |
每股收益（稀释后）EVIROG
| Q1 26 | — | $0.25 | ||
| Q4 25 | $0.15 | $0.20 | ||
| Q3 25 | $0.11 | $0.48 | ||
| Q2 25 | $0.14 | $-4.00 | ||
| Q1 25 | $0.07 | $-0.08 | ||
| Q4 24 | $0.07 | $-0.04 | ||
| Q3 24 | $0.21 | $0.58 | ||
| Q2 24 | $0.13 | $0.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $195.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $144.0M | $1.2B |
| 总资产 | $315.6M | $1.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资EVIROG
| Q1 26 | — | $195.8M | ||
| Q4 25 | — | $197.0M | ||
| Q3 25 | $4.7M | $167.8M | ||
| Q2 25 | $8.9M | $157.2M | ||
| Q1 25 | $5.9M | $175.6M | ||
| Q4 24 | $3.9M | $159.8M | ||
| Q3 24 | $4.4M | $146.4M | ||
| Q2 24 | $4.6M | $119.9M |
总债务EVIROG
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $24.0M | — | ||
| Q4 24 | $27.9M | — | ||
| Q3 24 | $19.9M | — | ||
| Q2 24 | $12.9M | — |
股东权益EVIROG
| Q1 26 | — | $1.2B | ||
| Q4 25 | $144.0M | $1.2B | ||
| Q3 25 | $140.8M | $1.2B | ||
| Q2 25 | $143.5M | $1.2B | ||
| Q1 25 | $140.2M | $1.3B | ||
| Q4 24 | $138.0M | $1.3B | ||
| Q3 24 | $136.1M | $1.3B | ||
| Q2 24 | $136.6M | $1.3B |
总资产EVIROG
| Q1 26 | — | $1.4B | ||
| Q4 25 | $315.6M | $1.4B | ||
| Q3 25 | $321.8M | $1.4B | ||
| Q2 25 | $307.0M | $1.5B | ||
| Q1 25 | $251.8M | $1.5B | ||
| Q4 24 | $248.8M | $1.5B | ||
| Q3 24 | $245.5M | $1.5B | ||
| Q2 24 | $230.7M | $1.5B |
负债/权益比EVIROG
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.17× | — | ||
| Q4 24 | 0.20× | — | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | 0.09× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.0M | $5.8M |
| 自由现金流经营现金流 - 资本支出 | — | $1.1M |
| 自由现金流率自由现金流/营收 | — | 0.5% |
| 资本支出强度资本支出/营收 | — | 2.3% |
| 现金转化率经营现金流/净利润 | 1.70× | 1.29× |
| 过去12个月自由现金流最近4个季度 | — | $70.1M |
8季度趋势，按日历期对齐
经营现金流EVIROG
| Q1 26 | — | $5.8M | ||
| Q4 25 | $4.0M | $46.9M | ||
| Q3 25 | $1.0M | $28.9M | ||
| Q2 25 | $9.9M | $13.7M | ||
| Q1 25 | $9.1M | $11.7M | ||
| Q4 24 | $2.0M | $33.7M | ||
| Q3 24 | $207.0K | $42.4M | ||
| Q2 24 | $12.4M | $22.9M |
自由现金流EVIROG
| Q1 26 | — | $1.1M | ||
| Q4 25 | — | $42.2M | ||
| Q3 25 | $-890.0K | $21.2M | ||
| Q2 25 | $8.2M | $5.6M | ||
| Q1 25 | $8.1M | $2.1M | ||
| Q4 24 | $1.1M | $18.3M | ||
| Q3 24 | $-1.0M | $25.2M | ||
| Q2 24 | $11.2M | $8.8M |
自由现金流率EVIROG
| Q1 26 | — | 0.5% | ||
| Q4 25 | — | 20.9% | ||
| Q3 25 | -0.8% | 9.8% | ||
| Q2 25 | 7.5% | 2.8% | ||
| Q1 25 | 8.7% | 1.1% | ||
| Q4 24 | 1.2% | 9.5% | ||
| Q3 24 | -1.1% | 12.0% | ||
| Q2 24 | 12.4% | 4.1% |
资本支出强度EVIROG
| Q1 26 | — | 2.3% | ||
| Q4 25 | — | 2.3% | ||
| Q3 25 | 1.8% | 3.6% | ||
| Q2 25 | 1.5% | 4.0% | ||
| Q1 25 | 1.1% | 5.0% | ||
| Q4 24 | 0.9% | 8.0% | ||
| Q3 24 | 1.3% | 8.2% | ||
| Q2 24 | 1.3% | 6.6% |
现金转化率EVIROG
| Q1 26 | — | 1.29× | ||
| Q4 25 | 1.70× | 10.20× | ||
| Q3 25 | 0.55× | 3.36× | ||
| Q2 25 | 4.74× | — | ||
| Q1 25 | 8.79× | — | ||
| Q4 24 | 1.74× | — | ||
| Q3 24 | 0.06× | 3.96× | ||
| Q2 24 | 5.99× | 2.83× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
